Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127685791 | 12768579 | 1 | I | 20150630 | 20160913 | 20160921 | 20160921 | EXP | ES-PURDUE-GBR-2016-0040569 | PURDUE | 76.00 | YR | F | Y | 0.00000 | 20160915 | PH | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127685791 | 12768579 | 1 | PS | Targin 10mg/5mg Comprimidos de liberacion prolongada | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Oral | 2 DF, BID | U | U | 205777 | 2 | DF | PROLONGED-RELEASE TABLET | |||||
| 127685791 | 12768579 | 2 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Oral | 10 MG, BID | U | U | 0 | 10 | MG | ||||||
| 127685791 | 12768579 | 3 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 20 MG, DAILY | U | 0 | 20 | MG | ||||||||
| 127685791 | 12768579 | 4 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 15 MG, DAILY | U | 0 | 15 | MG | ||||||||
| 127685791 | 12768579 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | 5 MG, DAILY | U | 0 | 5 | MG | ||||||||
| 127685791 | 12768579 | 6 | C | PAROXETINE. | PAROXETINE | 1 | 20 MG, DAILY | U | 0 | 20 | MG | ||||||||
| 127685791 | 12768579 | 7 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 25 MG, DAILY | U | 0 | 25 | MG | ||||||||
| 127685791 | 12768579 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | 0 | ||||||||||
| 127685791 | 12768579 | 9 | C | DIGOXIN. | DIGOXIN | 1 | 0.25 MG, BID | U | 0 | .25 | MG | ||||||||
| 127685791 | 12768579 | 10 | C | SINTROM | ACENOCOUMAROL | 1 | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127685791 | 12768579 | 1 | Product used for unknown indication |
| 127685791 | 12768579 | 2 | Product used for unknown indication |
| 127685791 | 12768579 | 3 | Product used for unknown indication |
| 127685791 | 12768579 | 4 | Product used for unknown indication |
| 127685791 | 12768579 | 5 | Product used for unknown indication |
| 127685791 | 12768579 | 6 | Product used for unknown indication |
| 127685791 | 12768579 | 7 | Product used for unknown indication |
| 127685791 | 12768579 | 8 | Product used for unknown indication |
| 127685791 | 12768579 | 9 | Product used for unknown indication |
| 127685791 | 12768579 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127685791 | 12768579 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127685791 | 12768579 | Conduct disorder | |
| 127685791 | 12768579 | Confusional state |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127685791 | 12768579 | 1 | 2015 | 20150730 | 0 | |
| 127685791 | 12768579 | 2 | 2015 | 20150730 | 0 | |
| 127685791 | 12768579 | 9 | 20150730 | 0 |